DK3290436T3 - Phenylalanin-fri protein til behandlingen af pku - Google Patents

Phenylalanin-fri protein til behandlingen af pku Download PDF

Info

Publication number
DK3290436T3
DK3290436T3 DK16186895.5T DK16186895T DK3290436T3 DK 3290436 T3 DK3290436 T3 DK 3290436T3 DK 16186895 T DK16186895 T DK 16186895T DK 3290436 T3 DK3290436 T3 DK 3290436T3
Authority
DK
Denmark
Prior art keywords
pku
phenylalanine
treatment
free protein
protein
Prior art date
Application number
DK16186895.5T
Other languages
English (en)
Inventor
Bernhard Hoffmann
Yvonne Mücke
Stefan Rasche
Natalia Jablonka
Stefan Schillberg
Original Assignee
Metax Inst Fuer Diaetetik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metax Inst Fuer Diaetetik Gmbh filed Critical Metax Inst Fuer Diaetetik Gmbh
Application granted granted Critical
Publication of DK3290436T3 publication Critical patent/DK3290436T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • General Preparation And Processing Of Foods (AREA)
DK16186895.5T 2016-09-01 2016-09-01 Phenylalanin-fri protein til behandlingen af pku DK3290436T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16186895.5A EP3290436B1 (en) 2016-09-01 2016-09-01 Phenylalanine-free protein for the treatment of pku

Publications (1)

Publication Number Publication Date
DK3290436T3 true DK3290436T3 (da) 2019-08-19

Family

ID=56883591

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16186895.5T DK3290436T3 (da) 2016-09-01 2016-09-01 Phenylalanin-fri protein til behandlingen af pku

Country Status (28)

Country Link
US (1) US10640538B2 (da)
EP (1) EP3290436B1 (da)
JP (1) JP6954676B2 (da)
CN (1) CN109661401B (da)
AU (1) AU2017317652B2 (da)
BR (1) BR112019004270A2 (da)
CA (1) CA3033271C (da)
CY (1) CY1121886T1 (da)
DK (1) DK3290436T3 (da)
ES (1) ES2742175T3 (da)
HR (1) HRP20191406T1 (da)
HU (1) HUE044665T2 (da)
IL (1) IL265015B2 (da)
LT (1) LT3290436T (da)
MA (1) MA43352B1 (da)
MD (1) MD3290436T2 (da)
ME (1) ME03510B (da)
MX (1) MX378970B (da)
NZ (1) NZ750498A (da)
PL (1) PL3290436T3 (da)
PT (1) PT3290436T (da)
RU (1) RU2764796C2 (da)
SA (1) SA519401175B1 (da)
SI (1) SI3290436T1 (da)
SM (1) SMT201900464T1 (da)
UA (1) UA124630C2 (da)
WO (1) WO2018041920A1 (da)
ZA (1) ZA201901505B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110747218A (zh) * 2019-09-27 2020-02-04 深圳市诺维健生物技术有限责任公司 一种特殊膳食蛋白质的生产方法与应用
CN110746494B (zh) * 2019-09-27 2021-07-20 深圳市诺维健生物技术有限责任公司 一组特殊膳食蛋白质

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04126051A (ja) * 1990-09-18 1992-04-27 Snow Brand Milk Prod Co Ltd フェニルケトン尿症患者用栄養調製物
GB9310472D0 (en) 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
GB9314802D0 (en) * 1993-07-16 1993-08-25 Pharmaceutical Proteins Ltd Modified proteins
AU4413096A (en) 1994-12-02 1996-06-19 Indiana University Foundation Phenylalanine free proteins
EP1092769B1 (de) * 1999-10-15 2008-10-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Polypeptid-Tag's für den Nachweis und die Aufreinigung von Polypeptiden
CA2437081C (en) * 2000-12-07 2010-10-19 Dsm Ip Assets B.V. Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
US9034402B2 (en) * 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
WO2010124180A1 (en) * 2009-04-23 2010-10-28 Phasebio Pharmaceuticals, Inc. Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
EP2831097A4 (en) 2012-03-26 2016-01-20 Pronutria Inc NUTRIENT FRAGMENTS AND PROTEINS WITH LOW OR NO PHENYLALANINANTEIL AND METHOD
CA2892021A1 (en) 2012-11-20 2014-05-30 Pronutria, Inc. Engineered secreted proteins and methods
ES2896401T3 (es) 2014-09-22 2022-02-24 Tanea Medical Ab Proteínas recombinantes exentas de Phe para su uso en el tratamiento de la fenilcetonuria

Also Published As

Publication number Publication date
ES2742175T3 (es) 2020-02-13
SI3290436T1 (sl) 2019-11-29
RU2019109142A3 (da) 2021-01-27
WO2018041920A1 (en) 2018-03-08
US10640538B2 (en) 2020-05-05
BR112019004270A2 (pt) 2019-06-04
CN109661401A (zh) 2019-04-19
IL265015A (da) 2019-04-30
ZA201901505B (en) 2020-08-26
CN109661401B (zh) 2023-12-19
HRP20191406T1 (hr) 2019-11-15
MX378970B (es) 2025-03-10
SA519401175B1 (ar) 2022-01-08
HUE044665T2 (hu) 2019-11-28
CA3033271A1 (en) 2018-03-08
SMT201900464T1 (it) 2020-01-14
IL265015B1 (en) 2024-04-01
CA3033271C (en) 2024-04-02
MD3290436T2 (ro) 2019-10-31
MX2019002422A (es) 2019-07-04
RU2019109142A (ru) 2020-10-01
AU2017317652A1 (en) 2019-02-28
JP2019533988A (ja) 2019-11-28
PL3290436T3 (pl) 2020-01-31
PT3290436T (pt) 2019-08-30
JP6954676B2 (ja) 2021-10-27
AU2017317652B2 (en) 2020-11-19
NZ750498A (en) 2023-01-27
CY1121886T1 (el) 2020-10-14
UA124630C2 (uk) 2021-10-20
EP3290436A1 (en) 2018-03-07
EP3290436B1 (en) 2019-06-05
ME03510B (me) 2020-04-20
IL265015B2 (en) 2024-08-01
RU2764796C2 (ru) 2022-01-21
MA43352A (fr) 2018-03-07
US20190202872A1 (en) 2019-07-04
MA43352B1 (fr) 2019-08-30
LT3290436T (lt) 2019-10-10

Similar Documents

Publication Publication Date Title
DK3501542T3 (da) Esketamin til behandling af depression
DK3570844T3 (da) Azolopyrimidin til behandlingen af kræftrelaterede lidelser
DK3326641T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3096798T3 (da) Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem
DK3439635T3 (da) Formuleringer til behandling af fast tumor
DK3288581T3 (da) Fremgangsmåde til behandling af cancer
DK3504187T3 (da) Anvendelse af pridopidin til behandling af funktionel tilbagegang
DK3331915T3 (da) Immun-checkpoint-inhibitorer til anvendelse til behandling af blodbårne cancere
IL264143B (en) Processes for preparing olaparib
DK3503890T3 (da) Anvendelse af pridopidin til behandling af dystonier
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3609529T3 (da) Rna til behandling af autoimmune sygdomme
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3242947T3 (da) Genterapi og elektroporese til behandling af maligniteter
DK3524255T3 (da) Sammensætning til behandling af acne
DK3730511T3 (da) Proteinoprensning
DK3400072T3 (da) Formuleringer til behandling af blærecancer
DK3430143T3 (da) Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme
DK3468604T3 (da) Farmaceutiske kombinationer til behandling af cancer
DK3331610T3 (da) Midler til anvendelse til behandling af gliom
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3578562T3 (da) L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme
DK3585808T3 (da) Modificerede serpiner til behandlingen af bradykinin formidlet sygdom
EP3493821A4 (en) METHOD OF TREATING THE RESPIRATORY TRACT
DK3618845T3 (da) Peptider til behandling af diabetes